pharma

Natalie Yeadon

Working with, Advocating for, and Empowering Patients

Natalie Yeadon - May 28, 2020 0

A version of this article was previously published on Pharmaphorum. In recent years, there has been a clear shift in Pharma when it comes to...

Tommaso Salanitri

Medical Affairs and Stakeholder Engagement in an Evolving Healthcare Scenario

Tommaso Salanitri - May 4, 2020 0

Due to unprecedented challenging situation and the current pandemic time, stakeholders needs are changing and these uncertain times are accelerating approaches already existing within...

Natalie Yeadon

“Fake News” and Credibility in Medical Publishing

Natalie Yeadon - April 3, 2020 0

A version of this article was previously published on Pharmaphorum. Doubtlessly, one of the defining phrases of the 2010s is “fake news.” We hear it...

Natalie Yeadon

“Go-to-Market”: Medical Affairs, Strategies and Timings

Tommaso Salanitri - February 2, 2020 0

“Go-to-Market” in Pharma is defined as a tactical action plan, that outlines the needed steps to succeed in a new market/therapeutic area. A “Go-to-Market” strategy...

Tommaso Salanitri

Field Medical Affairs In Pharma/Biotech: Effectiveness, Opportunities and Challenges

Tommaso Salanitri - January 8, 2020 0

Medical Affairs has risen very fast in the last years, becoming after an initial phase of “supporting function”, a highly crucial “leading function”, representing...

Natalie Yeadon

Navigating Emerging Markets – Opportunities and Challenges for Pharma

Natalie Yeadon - January 7, 2020 0

The pharmaceutical industry is quickly evolving; to stay relevant and competitive, companies need to stay on top of the most recent trends and technologies....

Natalie Yeadon

The Zeigarnik Effect – What is it and how can it help increase productivity?

Natalie Yeadon - January 7, 2020 0

As I discussed in my recent webinar on the power of habit, habits, whether conscious or subconscious, are the cause of about 40-45% of...

Stay on op - Ge the daily news in your inbox